| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |